Dimenium 50 mikrograma + 100 mikrograma u jednoj dozi, prašak inhalata, dozirani Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dimenium 50 mikrograma + 100 mikrograma u jednoj dozi, prašak inhalata, dozirani

elpen pharmaceutical co.inc. (sa), 95, marathonos ave., pikermi, attica, grčka - salmeterolksinafoat flutikazonpropionat - prašak inhalata, dozirani - 50 mikrograma + 100 mikrograma - urbroj: jedna doza praška inhalata sadrži 50 mikrograma salmeterola u obliku salmeterolksinafoata i 100 mikrograma flutikazonpropionata

Pinmirol 10 mg/ 10 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pinmirol 10 mg/ 10 mg tvrde kapsule

genericon pharma gesellschaft m.b.h., hafnerstraße 211, graz, austrija - ramipril amlodipinbesilat - kapsula, tvrda - 10 mg + 10 mg - urbroj: jedna kapsula sadrži 10 mg ramiprila i 10 mg amlodipina (u obliku amlodipinbesilata)

Ketonal 100 mg čepići Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

ketonal 100 mg čepići

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - ketoprofen - čepić - 100 mg - urbroj: jedan čepić sadrži 100 mg ketoprofena

Palonozetron Kalceks 250 mikrograma otopina za injekciju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

palonozetron kalceks 250 mikrograma otopina za injekciju

as kalceks, krustpils iela 71e, riga, latvija - palonozetronklorid - otopina za injekciju - urbroj: jedan ml otopine sadrži 50 mikrograma palonozetrona (u obliku palonozetronklorida) jedna bočica otopine od 5 ml sadrži 250 mikrograma palonozetrona (u obliku palonozetronklorida)

RINGEROVA OTOPINA BRAUN 8.6 g/1000 mL+ 0.3 g/1000 mL+ 0.33 g/1000 mL otopina za infuziju Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

ringerova otopina braun 8.6 g/1000 ml+ 0.3 g/1000 ml+ 0.33 g/1000 ml otopina za infuziju

b.braun adria bh d.o.o. - kalcijumhlorid, kalijumhlorid, natrijumhlorid - otopina za infuziju - 8.6 g/1000 ml+ 0.3 g/1000 ml+ 0.33 g/1000 ml - 1000 ml otopine za infuziju sadrži: 8,6 g natrijumhlorid 0,3 g kalijumhlorid 0,33 g kalcijumhlorid, dihidrat

RINGEROVA OTOPINA BRAUN 8.6 g/1000 mL+ 0.3 g/1000 mL+ 0.33 g/1000 mL otopina za infuziju Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

ringerova otopina braun 8.6 g/1000 ml+ 0.3 g/1000 ml+ 0.33 g/1000 ml otopina za infuziju

b.braun adria bh d.o.o. - kalcijumhlorid, kalijumhlorid, natrijumhlorid - otopina za infuziju - 8.6 g/1000 ml+ 0.3 g/1000 ml+ 0.33 g/1000 ml - 1000 ml otopine sadrži; 8,6 g natrijumhlorid 0,30 g kalijumhlorid 0,33 g kalcijumhlorid, dihidrat

Pemetrexed Pfizer (previously Pemetrexed Hospira) Europska Unija - hrvatski - EMA (European Medicines Agency)

pemetrexed pfizer (previously pemetrexed hospira)

pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Zynlonta Europska Unija - hrvatski - EMA (European Medicines Agency)

zynlonta

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastična sredstva - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.

Dimenium 50 mikrograma + 250 mikrograma u jednoj dozi, prašak inhalata, dozirani Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dimenium 50 mikrograma + 250 mikrograma u jednoj dozi, prašak inhalata, dozirani

elpen pharmaceutical co.inc. (sa), 95, marathonos ave., pikermi, attica, grčka - salmeterolksinafoat flutikazonpropionat - prašak inhalata, dozirani - 50 mikrograma + 250 mikrograma - urbroj: jedna doza praška inhalata sadrži 50 mikrograma salmeterola u obliku salmeterolksinafoata i 250 mikrograma flutikazonpropionata

Dimenium 50 mikrograma + 500 mikrograma u jednoj dozi, prašak inhalata, dozirani Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dimenium 50 mikrograma + 500 mikrograma u jednoj dozi, prašak inhalata, dozirani

elpen pharmaceutical co.inc. (sa), 95, marathonos ave., pikermi, attica, grčka - salmeterolksinafoat flutikazonpropionat - prašak inhalata, dozirani - 50 mikrograma + 500 mikrograma - urbroj: jedna doza praška inhalata sadrži 50 mikrograma salmeterola u obliku salmeterolksinafoata i 500 mikrograma flutikazonpropionata